In sepsis, PCSK9 degrades low-density lipoprotein (LDL) receptors in hepatocytes and very low-density lipoprotein (VLDL) receptors in adipocytes, thereby diminishing pathogenic lipid uptake and clearance. This evidence concerns the gene PCSK9 and Sepsis.